Kapitalo Investimentos Ltda Horizon Therapeutics Public LTD CO Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$0.0 - $116.3 $0 - $45.3 Million	-389,390 Closed	0 $0
Q3 2023 Mar 29, 2024	BUY	$98.98 - $115.74 $8.08 Million - $9.45 Million	81,620 Added 26.52%	389,390 $45 Billion
Q2 2023 Mar 29, 2024	BUY	$96.34 - $112.38 $5.82 Million - $6.79 Million	60,449 Added 24.44%	307,770 $31.7 Billion
Q1 2023 Mar 29, 2024	BUY	$107.32 - $113.5 $26.5 Million - $28.1 Million	247,321 New	247,321 $27 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.